Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Jan 23, 2012 4:34pm
327 Views
Post# 19438541

observations...

observations...

Slow day...stock moving down slowly...low volume...closing lower on recent successive days. We do not knowif the mini trend has legs yet.

Just looking at the BTI chart with a peak at $1.27...and now at $1.14....it could consolidate down to the $1 area...which would be a healthy pullback for next upleg with news. Most junior stocks with such a nice move up do retrace part of the sharp move...and a 50% retrace is common technically. This is not a negative occurence and would provide a nice buying opportunity again. If there is not good news in the next month or so, it may drift down until there is...with lower volumes.

If another Pharma study with option to license is announced, BTI should move up smartly. I am thinking that may be within a month or two...just  guess. We shall see. None of the above matters to longs who are here for the journey...which looks very positiive so far. It is understandable that some wiill sell/take profits if they got in much lower. 

'Risky' and J are traders and Risky said he made tons of $ on RVX as it bounced down from $26 to $1.10 over a few years. I haven't checked his postings over all that time over there so cannot be definitiive on his comments but it will be there for the record...and I do not know what his alias was before he became Risky.So, if true, stock was sold at the peaks or shorted and purchased on the dips by him. That;s amazing !

If I was a betting man, I'd bet the traders are selling bits on this down leg. Not saying that there is anything wrong with that unless one is pumping at selective times...or talking  'buyout' at this very premature time.

I noticed that Dr J. lives in Calgary, Risky lives inCal/Edm., Briscoe Capital (BTI's new IR Frim) is in Calgary; and RVX is in Calgary. Coincidences.

Bullboard Posts